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i g h l i g h t s
Cadmium causes a necrotic cell death in endothelial cells.
Cd-induced necrosis is a programmed, BCL-XL-inhibitable process.
Lysosomal membrane permeabilization and release of DNAse II are central in the execution of cell death.
DNAse-mediated degradation of nuclear DNA results in “apoptosis mimicry” in several cell death assays.
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a b s t r a c t
Cadmium is ahighly toxic, carcinogenic, and atherogenic element. A central principle inmanyCd-induced
pathophysiologies is the inductionof cell death. In past studies Cdwas shown to cause apoptosis, necrosis,
programmednecrosis, or autophagy. This studywas conducted toprecisely deﬁne the end stageprocesses
andoutcomeof Cd-induced cell death in endothelial cells (ECs).We showthat Cd leads to acidiﬁcation and
permeabilization of lysosomes, followed by the release of active DNAse II from lysosomes. The absenceeywords:
ysosome
ell death
ecrosis
NA degradation
of nuclear DNA due to DNAse II activity may have lead to misinterpretations of the type of cell death
outcome in previous studies. Further, Cd-induced cell death is characterized by a massive release of
lactate dehydrogenase (LDH), a gold standardmarker for the occurrence of plasmamembrane rupture i.e.
necrosis. Importantly, lentivirus-based over-expression of the anti-apoptotic protein BCL-XL abrogates
lysosomal rupture, DNA degradation and LDH release, clearly indicating that Cd induces a programmed
necroNAse
cidiﬁcation
form of cell death with a
. Introduction
Cadmium (Cd) is a relatively rare toxic heavy metal and is found
n the earths’ crust from0.1 to 0.5g/g, and in the atmosphere from
.1 to 5.0ng/m3. Industrial activities, mainly zinc production and
he use of Cd in pigments, plastic stabilizers, and batteries have
igniﬁcantly increased the amount of Cd in the biosphere, and as a
onsequence Cd exposure of humans (The International Cadmium
ssociation; www.cadmium.org). The major source for Cd uptake
y (non-smoking) humans is food, and tobacco smoking approxi-
ately doubles the daily Cd uptake (ATSDR, 2009; Authority, 2009;
riberg and Nordberg, 1986; Jarup and Akesson, 2009). In the
uman body Cd has a half-life of 10–30 years and accumulates
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massively in organs like liver, kidney, and testes. Further, Abu-
Hayyeh et al. demonstrated that also the vascular system is another
target organ for Cd deposition (Cd concentrations of up to 20M
were observed in the aortic wall of heavy smokers) (Abu-Hayyeh
et al., 2001; ATSDR, 2009; Satarug and Moore, 2004; Staessen
et al., 2001). In past decades the health threat of chronic low
dose Cd exposure was underestimated. Accordingly, the European
Food Safety Authority has reduced the provisional tolerableweekly
intake from 7g/kg to 2.5g/kg in 2009 (Authority, 2011).
Apart from the well known toxic effects of Cd on liver, kid-
neys and testis, the International Agency for Research on Cancer
has classiﬁed Cd as a human carcinogen (Achanzar et al., 2001;
Benbrahim-Tallaa et al., 2007, 2009; CANCER, 1997; Joseph, 2009;
Waalkes, 2003), and recent studies, including ours, clearly indicate
that Cd is also a signiﬁcant risk factor for cardiovascular diseases
(Messner et al., 2009; Peters et al., 2010).At the cellular level Cd was demonstrated to impair cell cycle
progression and cell proliferation (Templeton and Liu, 2010), DNA
repair (Bertin and Averbeck, 2006), cell–cell adhesion (Prozialeck
et al., 2008), and Cd was also shown to cause cell death in a
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arge number of different cell types (Templeton and Liu, 2010).
ell death induction by Cd was ascribed to the causation of ER-
tress (Wang et al., 2009), mitochondrial depolarization (Messner
t al., 2009), increase in ceramides and calpain-activation (Lee and
hevenod, 2008), ROS-production (Yang et al., 2007), and DNA-
amage (Liu and Jan, 2000). Intriguingly, the reported ﬁnal outcome
f Cd-induced cell death is highly diverse, ranging from classi-
al apoptosis (Jung et al., 2008) and necrosis (Kaji et al., 1992;
ishimoto et al., 1991) to programmed necrosis (Messner et al.,
009) and autophagy (Dong et al., 2009).
This study was conducted to precisely deﬁne the ﬁnal outcome
f Cd-induced cell death in endothelial cells, and to study the cellu-
ar processes involved therein with a “bottom up” research strategy.
any previous studies on cadmium-induced cell death focussed
rimarily on upstream signalling analyses, lacking a hard fact char-
cterization of the ultimate outcome. As the endpoint of cell death
eﬁnes whether an agent (Cd) causes inﬂammation (necrosis) or
ot (apoptosis), the clear deﬁnition of the mode of cell death is
rucial for the pathophysiological understanding of Cd-caused dis-
ases.
. Materials and methods
.1.  General
All reagents used were of purissimum or analytical grade quality and were
urchased  from Sigma–Aldrich (Sigma–Aldrich, Vienna, Austria) unless speciﬁed
therwise.
.2.  Cell isolation and culture
The  isolation and culture of human umbilical vein endothelial cells (HUVECs)
as  been described previously (Bernhard et al., 2003). The isolation and analysis of
UVECs were approved by the Ethics Committee of the Medical University of Inns-
ruck (No.: UN2979) and the Ethics Committee of the Medical University of Vienna
EK Nr. 1183/2012). Cells were routinely passaged in 0.2% gelatine-coated (Sigma,
teinheim, Germany) polysterene culture ﬂasks (TPP, Switzerland) in endothelial
rowth  medium (EGM, Lonza) in a humidiﬁed atmosphere containing 5% CO2. For
ell death analyses, 3 × 105 HUVECs per well were seeded onto gelatine-coated 6-
ell plates (TPP, Switzerland). Prior to each experiment, medium was replaced by
resh medium.
.3.  Generation of lentiviral vectors
BCL-XL  viruses: For constitutive over-expression of human BCL-XL in HUVECs,
CL-XL  encoding cDNA was  PCR ampliﬁed and recombined into pDONR-207 (Invit-
ogen) using Invitrogen’s B/P recombination kit. A sequence veriﬁed clone was
sed for L/R recombination with pHR-SFFV-dest-IRES-Puro thereby generating the
entiviral expression plasmid pHR-SFFV-BCLXL-IRES-Puro (Sigl et al., 2009).
.4. Generation of stable BCL-XL over-expressing HUVECs
For lentiviral transduction, human HEK 293T cells were transiently transfected
ith  lentiviral plasmids containing cDNAs coding for human BCL-XL or eGFP, along
ith the packaging plasmids pCMV 8.91 and pVSV-G (kindly provided by Didier
rono). Forty eight and 72 h after transfection lentiviral supernatant was sterile ﬁl-
ered (0.2 M),  supplemented with polybrene to a ﬁnal concentration of 4 g/ml
nd  added to the target cells overnight.
.5. Quantiﬁcation of cell death
For  detection and/or quantiﬁcation of cell death, forward/sideward light scat-
ering  analysis and AnnexinV/propidium iodide-staining were used as described
Bernhard  et al., 2003). AnnexinV/PI− staining allows the discrimination of intact
iable  cells (AnnexinV− negative and PI− negative), early apoptotic (AnnexinV−
ositive  and PI− negative) and necrotic cells (AnnexinV− positive and PI− positive).
.6.  Analysis of number of viable cellsThe  number of viable cells was determined using the XTT assay (Biomol GmbH,
amburg,  Germany). HUVECs were seeded into gelatine coated 96-well plates. After
4 h the medium was  replaced by fresh medium and the cells were treated with vari-
us Cd concentrations for the indicated times. For further details see manufacturers’
nstructions.ters 212 (2012) 268– 275 269
2.7. Lactate dehydrogenase release assay
The amount of lactate dehydrogenase (LDH) released from cells was quanti-
ﬁed  using the LDH cytotoxicity kit II (Biovision) according to the manufacturer’s
instructions.
2.8.  Quantiﬁcation of cellular DNA content
For the detection and quantiﬁcation of nuclear DNA content, HUVECs were
seeded  into gelatine coated 6-well plates and allowed to adhere over night. After
replacing the medium with fresh medium, the cells were incubated with various Cd
concentrations for the indicated times. After enzymatic detachment, the cells were
permeabilized with saponin (1 mg/ml), stained with propidium iodide (50 g/ml)
and analysed and quantiﬁed by ﬂowcytometry using a Cytomics FC 500 (Beckmann
Coulter,  Brea, CA, USA).
2.9.  Staining of cells and ﬂuorescence microscopy
To analyse the subcellular localization of DNAse II, HUVECs were treated with
Cd for the indicated times. After treatment, the cells were washed with PBS and
ﬁxed with 4% PFA for 3 min at room temperature. Fixed cells were washed with
PBS and permeabilized with 0.3% Triton X-100 for 30 min. Following an additional
washing  step with PBS, non-speciﬁc binding sites were blocked with 1% bovine
serum  albumin (BSA) in PBS for 30 min at room temperature followed by staining
with primary antibody against DNAse II (mouse polyclonal antibody, Abnova GmbH,
Heidelberg, Germany; 10 g/ml) for 1 h at room temperature. After 3 washing steps
with PBS, the cells were incubated with secondary antibody (Alexa Fluor 488, goat
anti-mouse, Invitrogen, Carlsbad, CA, USA) for 1 h in the dark and at room tempera-
ture.  Thereafter, the monolayer was washed 3 times with PBS and nuclear staining
was performed using propidium iodide (1 g/ml) for 8 min  at room temperature in
the dark. After 3 ﬁnal washing steps, cells were mounted in ProLong Gold (Invitro-
gen,  Carlsbad, CA, USA) and analysed using a LSM 510 Meta attached to an Axioplan
2  imaging MOT  using ZEN software (Zeiss, Oberkochen, Germany).
2.10.  In vitro DNA laddering
To  analyse cytosolic nuclease activity of Cd treated HUVECs, nuclear DNA was
extracted  from endothelial cells using a DNA puriﬁcation kit (Promega GmbH,
USA).  Nuclear DNA (2 g) was then incubated with cytosolic extracts of Cd-treated
HUVECs  and controls (30 g) for 3 h at 37 ◦C. DNA fragmentation was  analysed by
agarose gel electrophoresis (0.5%).
2.11. Lysosomal labelling and pH imaging
For the staining of acidic compartments in HUVECs, LysoTracker green was
used  (Invitrogen, Molecular Probes, USA). After Cd treatment of cells for the indi-
cated times, HUVECs were stained with LysoTracker dye (75 nM)  for 30 min  at
37 ◦C. The cells were then analysed using a LSM 510 Meta attached to an Axio-
plan  2 imaging MOT  using ZEN software (Zeiss, Oberkochen, Germany) or by FACS
analysis.
For the imaging of pH-changes, LysoSensor green was used (Invitrogen, Molec-
ular  Probes, USA). After Cd treatment of cells for the indicated times, HUVECs were
stained with LysoSensor probe (75 nM)  for 5 min  at 37 ◦C. Endothelial cells were
analysed  using a LSM 510 Meta attached to an Axioplan 2 imaging MOT  using ZEN
software (Zeiss, Oberkochen, Germany) or by FACS analysis.
2.12.  Western blotting
Western blotting was performed as previously described (Bernhard et al., 2001).
Equal amounts of protein were loaded. Primary antibody used was anti-LC3 (rabbit
anti-LC3; Sigma–Aldrich, Cat. No.: L8918). Quantiﬁcation of bands was performed
using  Quantity One Software (Quantity one, Biorad).
2.13.  In vivo experimentation
The mouse aortic sections analysed in this study were obtained in the course of
a previous study (Messner et al., 2009). The animal experiment was  approved by the
Animal Ethics Committee of the Austrian Federal Ministry for Research and Science.
Eight female ApoE knock out mice were divided randomly into 2 groups. The control
group received normal water and the Cadmium group was treated with 100 mg/L
of CdCl2 in the drinking water. Both groups were fed a Western type diet to induce
the  development of atherosclerotic plaques. After 12 weeks of treatment the aorta
was excised between the aortic arch and the iliac bifurcation. The aorta was cleaned
by removing connective tissue and fat, washed in PBS and ﬁxed immediately in 4%
paraformaldehyde. After ﬁxation and dehydration aortas were embedded in parafﬁn
and 5 m sections were prepared.
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.14.  Haematoxylin eosin staining
After  deparafﬁnization, histochemical staining was performed. Sections were
ehydrated,  washed in A.d. and stained 1 min  with Mayers Hemalaun solution
Merck;  Cat. No.: 1.09249) and washed in tap water for 20 min. Subsequently the
ections were counterstained with 0.1% eosin (Merck, Cat. No.: 1.15935; containing 1
rop glacial acetic acid/100 ml  eosin solution). After a further washing step in A.d. the
ections were dehydrated and mounted in Histokitt (Roth, Cat. No.: 6638.1). Image
cquisition was  conducted with AxioVision Rel. 4.8 software (Zeiss, Oberkochen,
ermany).
.15.  Statistical analysis
Where indicated primary data were tested for a Gaussian distribution and equal-
ty  of variances. Further analyses were performed using T-test.
. Results
.1. Low dose cadmium induces BCL-XL inhibitable necrotic
ndothelial cell death
In  order to deﬁne the ﬁnal outcome of Cd-induced cell death
n endothelial cells, HUVECs were incubated with various con-
entrations of Cd for various times and subjected to cell death
nalysis by AnnexinV–propidium iodide staining, the formazan-
ased XTT assay, as well as LDH release assays. Cell death analysis
y AnnexinV–propidium iodide staining suggests that endothe-
ial cells undergo massive apoptosis in response to Cd treatment
Fig. 1A). XTT assays, which essentially measure the number of
iable cells were in good agreement with AnnexinV–propidium
odide data (Fig. 1B and C). Surprisingly however, lactate dehydro-
enase (LDH) release assays (Fig. 1D and E) showed that the increase
n “apoptotic” cells (Fig. 1A) by Cd treatment is perfectly corre-
ated to LDH release, which is a clear marker for plasma membrane
upture i.e. necrosis.
Cd-induced cell death induction could be signiﬁcantly inhibited
y the over-expression of BCL-XL (Fig. 1C and E).
.2. Cadmium reduces the cellular DNA content by activating
NAse II
In  order to reveal the reason for the absence of propidium iodide
ositivity in AnnexinV–propidium iodide analyses in the presence
f a massive LDH release in Cd-treated endothelial cells, we  ana-
ysed the cellular DNA content in Cd exposed ECs. As can be seen in
ig. 2A, Cd treatment resulted in a dose and time dependent reduc-
ion in cellular DNA content, a phenomenon that was  also inhibited
y BCL-XL over-expression (Fig. 2B). To conﬁrm these results we
lso analysed Cd exposed HUVECs by ﬂuorescence microscopy. In
ddition to DNA staining (red), cells were also stained for sev-
ral DNAses by means of immunohistochemistry. As can be seen
n Fig. 2C, the cellular distribution of DNAse II (green) changes
rom a punctuate, non-nuclear patter to a more diffuse, cytoso-
ic and nuclear pattern. The appearance of DNAse II in the nuclear
egion is accompanied by an early ﬂash in DNA staining intensity
see Fig. 2C: HUVECs 24 h, 30 M Cd), which is likely caused by
NAse-caused uncoiling of DNA, and better access of the DNA dye,
ollowed by a gradual reduction of DNA signal until almost com-
lete absence of the DNA signal (Fig. 2C: HUVECs, 72 h, 30 M).
ike cell death, also Cd-induced DNA degradation is signiﬁcantly
nhibited by BCL-XL over-expression (Fig. 2B). In order to conﬁrm
he presence of cytosolic DNAse activity in a cell free system, we
repared cytosolic extract of cells treated with different concentra-
ions of Cd for 72 and 96 h, and exposed intact genomic DNA (which
as isolated separately) to these extracts. As can be seen in Fig. 2D,
d-exposure of cells leads to DNAse activity in cytosolic extracts,
ndicated by the occurrence and increasing intensity of the DNAters 212 (2012) 268– 275
smear  as well as by the drop in molecular weight of the upper band
(Fig. 2D).
3.3.  Cadmium induces acidiﬁcation and permeabilization of
lysosomes
Since  DNAse II is normally located in the lysosomal compart-
ment of cells, we decided to study the integrity and acidity of
lysosomes in response to Cd-treatment of HUVECs. Fig. 3A–C shows
that Cd leads to signiﬁcantly acidiﬁcation of lysosomes, and that
the number of lysosomes signiﬁcantly decreases in Cd treated cells
(Fig. 3D). Due to DNAse activity observed in the cytosol of Cd treated
cells, the observed decrease in lysosomal mass is highly likely to
be a result of lysosomal permeabilization. BCL-XL over-expression,
was capable of potently inhibiting lysosomal permeabilization, and
even seemed to stabilize or increase lysosomes in response to Cd
treatment (Fig. 3E). As lysosomal acidiﬁcation is well known to
occur in the course of autophagic signalling, we  assessed the ratio
of LC3 II per LC3 I, a gold standard marker for autophagy. As can be
seen in Fig. 3F the ratio LC3 II/I increased signiﬁcantly in response
to Cd treatment of cells. The images in Fig. 3G and H show a pH-
sensitive HE-staining of aortic sections of mice treated with Cd for
12 weeks via drinking water (Fig. 3H) and corresponding controls
(Fig. 3G). The more intensive red staining (increased acidity) of the
media of Cd-treated animals may  suggest that lysosomal acidiﬁca-
tion observed in vitro may  also occur in vivo.
4. Discussion
As published literature indicates that Cd induces apoptosis (Jung
et al., 2008), necrosis (Kaji et al., 1992; Kishimoto et al., 1991),
programmed necrosis (Messner et al., 2009), as well as autophagy
(Dong et al., 2009), this study was  conducted to precisely deﬁne
the ﬁnal faith of a cell exposed to death-inducing concentrations
of Cd. Based on the data presented herein Cd causes a necrotic,
yet programmed form of cell death in endothelial cells. The cen-
tral elements underlying these conclusions are (i) the inhibitability
of Cd-induced cell death by BCL-XL over-expression and (ii) the
massive release of LDH in response to Cd treatment.
BCL-XL is a member of the BCL2 protein family, consisting
of mitochondrial membrane pore forming pro-apoptotic proteins
(like BAX) and non-pore forming anti-apoptotic proteins (like
BCL-XL). The balance between these two groups deﬁnes whether
mitochondrial permeability transition (a central element in apop-
totic death execution) occurs or not. Likewise, BCL2 family proteins
have been shown to also regulate lysosomal membrane permeabi-
lization, being a crucial element in the programmed induction of
necrosis (Johansson et al., 2010).
Particularly previous studies reporting on the occurrence of apo-
ptosis, by using the AnnexinV–propidium iodide cell death assay,
may have reported false (apoptosis) positive results, as the degra-
dation of genomic DNA – induced by Cd – gives a perfect mimicry
of apoptosis.
Just like the ﬁnal outcome of Cd-induced cell death, also
the reported upstream signalling pathways are highly diverse.
Described death pathways include ER-stress (Wang et al., 2009),
mitochondrial depolarization (Messner et al., 2009), increase in
ceramides and calpain-activation (Lee and Thevenod, 2008), ROS-
production (Yang et al., 2007), and DNA-damage (Liu and Jan, 2000).
In summary, these data may  suggest that Cd-induced cell death is
highly cell type speciﬁc, or – what we  assume – that Cd activates
several different (probably cross talking) death signalling pathways
in parallel. The present study does not add new information to
the upstream signalling processes in Cd-induced death, however,
by deﬁning lysosomal permeabilization as a central downstream
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Fig. 1. Cadmium induces a necrotic, yet programmed form of cell death. (A) HUVECs were treated with 15 M and 30 M Cd for indicated times followed by AnnexinV/PI
staining. (B and C) XTT-based analyses of the number of viable cells of HUVECs (B) and BCL-XL over-expressing HUVECs (C) incubated with 15 M Cd or 30 M Cd for the
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times indicated. (D and E) Effect of Cd treatment on plasma membrane integrity. 
0  M Cd for the indicated times, followed by an analyses of LDH release. All expe
ver-expressing. Asterisks indicate signiﬁcant differences (*p < 0.05; **p < 0.01; ***p
vent in Cd-induced cell death the present data may  allow for chan-
elling of essential upstream signalling events. Phosphorylated P53
n serine 15, occurring as a response to DNA damage was  pre-
iously shown to integrate into lysosomal membranes leading to
heir permeabilization (Johansson et al., 2010).Cs (D) and BCL-XL over-expressing HUVECs (E) were incubated with 15 M Cd or
ts were repeated 4 times, and there were at least 2 parallels per experiment. OE –
1) compared to the corresponding controls.
ER stress and autophagic processes are known to lead
to acidiﬁcation of lysosomes (Kouroku et al., 2007). How-
ever, the present data do not clearly indicate that lysosomal
acidiﬁcation is the reason for lysosomal permeabilization, as
the decrease in lysosomal mass (permeabilization) preceded
272 B. Messner et al. / Toxicology Letters 212 (2012) 268– 275
Fig. 2. Cadmium induces DNA degeneration by activating DNAse II. (A and B) Data on the DNA content of HUVECs (A) and BCL-XL over-expressing HUVECs (B) treated with
15  M Cd or 30 M Cd for the indicated times. The DNA content was  analysed by FACS analyses. The images in (C) show an immunoﬂuorescence-based analysis of cellular
DNA (red) and localization of DNAse II (green) in response to Cd treatment of HUVECs and BCL-XL over-expressing HUVECs. Representative images are shown. (D) Data from
cell-free  analyses of cytosolic DNAse activity. Intact total genomic DNA was incubated with cytosolic extracts of controls and cells treated with 30 M Cd for 7 h and 96 h,
followed by analysis on a 0.5% agarose gel. 1 – indicates the drop in molecular weight of the upper genomic band due to Cd treatment; 2 – indicates the location of the
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cppearing smear, 3 – indicates the lower band. All experiments were repeated 3 tim
**p  < 0.001) compared to the corresponding controls. (For interpretation of the re
rticle.)cidiﬁcation. Nevertheless, the data shown in Fig. 3F indicate, that
utophagic signalling does occur in endothelial cells in response
o Cd exposure. Interestingly, we could previously show that
igarette smoke extract (cigarette smoke is the most importantE – over-expressing. Asterisks indicate signiﬁcant differences (*p < 0.05; **p < 0.01;
es to colour in this ﬁgure legend, the reader is referred to the web  version of thesource  for Cd uptake by non-occupationally exposed humans)
also induces autophagy. It may  be speculated that Cd is the
autophagy-inducing agent in cigarette smoke (Csordas et al.,
2011).
B. Messner et al. / Toxicology Letters 212 (2012) 268– 275 273
Fig. 3. Cadmium induces acidiﬁcation and permeabilization of lysosomes. (A and B) Data from LysoSensor-based FACS analyses of lysosomal pH-changes in HUVECs (A) and
BCL-XL  over-expressing cells (B) treated with Cd (15 M or 30 M)  for the indicated times. Additionally, confocal ﬂuorescence images of HUVECs stained with LysoSensor
are shown in (C). (D and E) Data of HUVECs (D) and BCL-XL over-expressing cells (E) incubated with 15 M Cd or 30 M Cd for the indicated times, followed by staining with
the lysosome dye LysoTracker. The number of lysosomes was quantiﬁed by FACS-analyses. (F) A Western blot-based quantiﬁcation of the ratio LC3 II per I. The increase in this
ratio  is a standard maker for the induction of autophagy. All experiments were repeated 3 times. OE – over-expressing. Asterisks indicate signiﬁcant differences (*p < 0.05;
**p  < 0.01; ***p < 0.001) compared to the corresponding controls. (G and H) A HE-staining of aortal sections of mice treated with Cd (H) and controls (G). The increase in red
staining indicates an increase in tissue acidity. Representative images are shown. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to
the  web version of the article.)
274 B. Messner et al. / Toxicology Let
Fig. 4. Schematic hypothetical sketch of Cd-induced cell death signalling and exe-
cution. After addition of Cd to endothelial cells, Cd enters the cells via ion channels or
pinocytosis. Intracellular Cd causes DNA damage (also via inhibition of DNA repair),
activates a protein misfolding response via endoplasmatic reticulum (ER) stress,
affects mitochondria (mt), Ca2+ homeostasis and induces the conversion of LC3 I to
LC3 II (autophagy signal). The relevant trigger for lysosomal acidiﬁcation and per-
meabilization is unclear at the moment, but both processes, lead to activation and
release of DNAse II, which digests DNA. Further, lysosomal permeabilization leads
to the release of degrading enzymes like proteases, lipases and other nucleases. The
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iegradation of cellular structures by these enzymes, leads to the break down of
hysiological functions and ultimately to plasma membrane rupture and a necrotic
ell death.
Lysosomes are highly redox sensitive organelles, and some pre-
ious studies have provided data that Cd induces the formation
f reactive oxygen species (ROS) and oxidative stress (Pathak and
handelwal, 2008; Yang et al., 2008). However, in our own previous
tudy the occurrence of oxidative stress in response to Cd treatment
f endothelial cells was ruled out as a mechanism in Cd-induced cell
eath (Messner et al., 2009).
Mitochondria are known to be interconnected to lysosomes, via
he mitochondrial–lysosomal axis. In essence, mitochondrial per-
eabilization can cause lysosomal permeabilization, via ROS, and
ysosomes can cause mitochondrial permeabilization via cathep-
ins (Jaattela, 2004; Johansson et al., 2010; Repnik et al., 2012).
s above, as the occurrence of ROS in Cd-induced cell death was
uled out, the present data suggest that it is rather that Cd-induced
ysosomal permeabilization causes mitochondrial permeabiliza-
ion, than the other way round. Finally, Ca2+ is known to be a
timulator of lysosomal permeabilization (Kroemer and Jaattela,
005). Sources for a cytosolic increase in Ca2+ are the extracellular
pace, mitochondria, and the ER. Hence, the involvement of extra-
ellular Ca2+, the ER, and mitochondria, all central elements in Ca2+
ignalling cannot be excluded as players in Cd-induced lysosomal
ermeabilization and necrosis.
. Conclusion
In summary, the data provided herein show that Cd-induced
ell death signalling, in the rather terminal stages, still 24 h prior
o plasma membrane rupture, leads to acidiﬁcation and permeabi-
ization of lysosomes. The disintegration of lysosomes, indicated
y the reduction in lysosomal dye signal intensity and the increase
f DNAse activity in the cytosol of Cd-treated cells leads to prote-
lysis, lipidolysis and digestion of nucleic acids – consequently to
he deterioration of physiological functions, ultimately resulting in
ellular necrosis (Fig. 4). The site of the inhibitory activity of BCL-
L could not deﬁnitely be demonstrated. Potential sites of activity
nclude permeabilization of mitochondria (also via ER stress andters 212 (2012) 268– 275
caspase-12) and lysosomes (Ferri and Kroemer, 2001; Johansson
et al., 2010). The ﬁnding that BCL-XL was  not capable of inhibiting
acidiﬁcation of lysosomes, but could inhibit their permeabilization,
may indicate a lysosomal inhibition site of BCL-XL.
By demonstrating that Cd causes a programmed form of cell
death with a necrotic endpoint the present study may  add to the
pathobiological understanding of Cd-induced death signalling, and
the pro-inﬂammatory, and pro-atherosclerotic activity of Cd in vivo
(Knoﬂach et al., 2011).
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